Trials / Conditions / Thyroid Gland Oncocytic Carcinoma
Thyroid Gland Oncocytic Carcinoma
3 registered clinical trials studyying Thyroid Gland Oncocytic Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With NCT06440850 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated T NCT03914300 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be R NCT00381641 | National Cancer Institute (NCI) | Phase 2 |